# Lumentum Holdings Inc.: financial statements, quarterly

LITE · Nasdaq · CIK 1633978 · [Technology](/sectors/technology.md) · fiscal year ends Jun 27

Pages: [Overview](/companies/lite.md) · [Financials](/companies/lite/financials.md) · [Filings](/companies/lite/filings.md) · [Insiders](/companies/lite/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lite/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-30) | Q3 FY2024 (2024-03-30) | Q4 FY2024 (2024-06-29) | Q1 FY2025 (2024-09-28) | Q2 FY2025 (2024-12-28) | Q3 FY2025 (2025-03-29) | Q4 FY2025 (2025-06-28) | Q1 FY2026 (2025-09-27) | Q2 FY2026 (2025-12-27) | Q3 FY2026 (2026-03-28) | Q4 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [318](/filings/0001628280-24-046443.md) | [367](/filings/0001628280-25-004288.md) | [367](/filings/0001628280-25-022788.md) | [308 d](/filings/0001628280-26-057358.md) | [337](/filings/0001628280-24-046443.md) | [402](/filings/0001628280-25-004288.md) | [425](/filings/0001628280-25-022788.md) | [481 d](/filings/0001628280-26-057358.md) | [534](/filings/0001628280-25-049073.md) | [666](/filings/0001628280-26-005129.md) | [808](/filings/0001628280-26-030777.md) | [1,006 d](/filings/0001628280-26-057358.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [76.7](/filings/0001628280-24-046443.md) | [64.0](/filings/0001628280-25-004288.md) | [59.5](/filings/0001628280-25-022788.md) | [51.3 d](/filings/0001628280-26-057358.md) | [77.9](/filings/0001628280-25-049073.md) | [99.6](/filings/0001628280-26-005129.md) | [123](/filings/0001628280-26-030777.md) | [160 d](/filings/0001628280-26-057358.md) | [182](/filings/0001628280-25-049073.md) | [240](/filings/0001628280-26-005129.md) | [357](/filings/0001628280-26-030777.md) | [477 d](/filings/0001628280-26-057358.md) |
| Research and development | $m | [73.5](/filings/0001628280-24-046443.md) | [78.3](/filings/0001628280-25-004288.md) | [77.2](/filings/0001628280-25-022788.md) | [73.2 d](/filings/0001628280-26-057358.md) | [74.3](/filings/0001628280-25-049073.md) | [74.2](/filings/0001628280-26-005129.md) | [75.9](/filings/0001628280-26-030777.md) | [79.5 d](/filings/0001628280-26-057358.md) | [81.4](/filings/0001628280-25-049073.md) | [80.1](/filings/0001628280-26-005129.md) | [90.6](/filings/0001628280-26-030777.md) | [104 d](/filings/0001628280-26-057358.md) |
| Selling, general and administrative | $m | [73.0](/filings/0001628280-24-046443.md) | [85.1](/filings/0001628280-25-004288.md) | [77.7](/filings/0001628280-25-022788.md) | [74.9 d](/filings/0001628280-26-057358.md) | [76.3](/filings/0001628280-25-049073.md) | [76.3](/filings/0001628280-26-005129.md) | [112](/filings/0001628280-26-030777.md) | [83.6 d](/filings/0001628280-26-057358.md) | [85.1](/filings/0001628280-25-049073.md) | [96.1](/filings/0001628280-26-005129.md) | [90.8](/filings/0001628280-26-030777.md) | [91.2 d](/filings/0001628280-26-057358.md) |
| Operating income | $m | [(80.8)](/filings/0001628280-24-046443.md) | [(105)](/filings/0001628280-25-004288.md) | [(115)](/filings/0001628280-25-022788.md) | [(133) d](/filings/0001628280-26-057358.md) | [(82.4)](/filings/0001628280-25-049073.md) | [(51.6)](/filings/0001628280-26-005129.md) | [(37.7)](/filings/0001628280-26-030777.md) | [(8.4) d](/filings/0001628280-26-057358.md) | [6.7](/filings/0001628280-25-049073.md) | [64.3](/filings/0001628280-26-005129.md) | [175](/filings/0001628280-26-030777.md) | [279 d](/filings/0001628280-26-057358.md) |
| Interest expense | $m | [9.7](/filings/0001628280-23-037591.md) | [9.7](/filings/0001628280-24-003796.md) | [9.0](/filings/0001628280-24-020767.md) | [5.4 d](/filings/0001628280-26-057358.md) | [5.5](/filings/0001628280-25-049073.md) | [5.6](/filings/0001628280-26-005129.md) | [5.7](/filings/0001628280-26-030777.md) | [5.4 d](/filings/0001628280-26-057358.md) | [5.7](/filings/0001628280-25-049073.md) | [6.3](/filings/0001628280-26-005129.md) | [6.2](/filings/0001628280-26-030777.md) | [3.6 d](/filings/0001628280-26-057358.md) |
| Income tax | $m | [(1.4)](/filings/0001628280-24-046443.md) | [(2.4)](/filings/0001628280-25-004288.md) | [19.6](/filings/0001628280-25-022788.md) | [125 d](/filings/0001628280-26-057358.md) | [3.2](/filings/0001628280-25-049073.md) | [18.6](/filings/0001628280-26-005129.md) | [4.9](/filings/0001628280-26-030777.md) | [(225) d](/filings/0001628280-26-057358.md) | [1.0](/filings/0001628280-25-049073.md) | [18.3](/filings/0001628280-26-005129.md) | [39.6](/filings/0001628280-26-030777.md) | [(297) d](/filings/0001628280-26-057358.md) |
| Net income | $m | [(67.9)](/filings/0001628280-25-022788.md) | [(99.1)](/filings/0001628280-25-022788.md) | [(127)](/filings/0001628280-25-022788.md) | [(253) d](/filings/0001628280-26-057358.md) | [(82.4)](/filings/0001628280-26-030777.md) | [(60.9)](/filings/0001628280-26-030777.md) | [(44.1)](/filings/0001628280-26-030777.md) | [213 d](/filings/0001628280-26-057358.md) | [4.2](/filings/0001628280-26-030777.md) | [78.2](/filings/0001628280-26-030777.md) | [144](/filings/0001628280-26-030777.md) | [(7,162) d](/filings/0001628280-26-057358.md) |
| Diluted EPS | $ per share | [(1.02)](/filings/0001628280-24-046443.md) | [(1.47)](/filings/0001628280-25-004288.md) | [(1.88)](/filings/0001628280-25-022788.md) | not reported | [(1.21)](/filings/0001628280-25-049073.md) | [(0.88)](/filings/0001628280-26-005129.md) | [(0.64)](/filings/0001628280-26-030777.md) | not reported | [0.05](/filings/0001628280-25-049073.md) | [0.89](/filings/0001628280-26-005129.md) | [1.50](/filings/0001628280-26-030777.md) | not reported |
| Basic EPS | $ per share | [(1.02)](/filings/0001628280-24-046443.md) | [(1.47)](/filings/0001628280-25-004288.md) | [(1.88)](/filings/0001628280-25-022788.md) | not reported | [(1.21)](/filings/0001628280-25-049073.md) | [(0.88)](/filings/0001628280-26-005129.md) | [(0.64)](/filings/0001628280-26-030777.md) | not reported | [0.06](/filings/0001628280-25-049073.md) | [1.10](/filings/0001628280-26-005129.md) | [1.99](/filings/0001628280-26-030777.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-30) | Q3 FY2024 (2024-03-30) | FY2024 (2024-06-29) | Q1 FY2025 (2024-09-28) | Q2 FY2025 (2024-12-28) | Q3 FY2025 (2025-03-29) | FY2025 (2025-06-28) | Q1 FY2026 (2025-09-27) | Q2 FY2026 (2025-12-27) | Q3 FY2026 (2026-03-28) | FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [862](/filings/0001628280-23-037591.md) | [469](/filings/0001628280-24-003796.md) | [425](/filings/0001628280-24-020767.md) | [437](/filings/0001628280-25-040830.md) | [489](/filings/0001628280-24-046443.md) | [480](/filings/0001628280-25-004288.md) | [516](/filings/0001628280-25-022788.md) | [521](/filings/0001628280-26-057358.md) | [773](/filings/0001628280-25-049073.md) | [658](/filings/0001628280-26-005129.md) | [2,618](/filings/0001628280-26-030777.md) | [2,044](/filings/0001628280-26-057358.md) |
| Current assets | $m | [2,692](/filings/0001628280-23-037591.md) | [2,062](/filings/0001628280-24-003796.md) | [1,650](/filings/0001628280-24-020767.md) | [1,590](/filings/0001628280-25-040830.md) | [1,636](/filings/0001628280-24-046443.md) | [1,651](/filings/0001628280-25-004288.md) | [1,667](/filings/0001628280-25-022788.md) | [1,717](/filings/0001628280-26-057358.md) | [2,086](/filings/0001628280-25-049073.md) | [2,283](/filings/0001628280-26-005129.md) | [4,396](/filings/0001628280-26-030777.md) | [4,162](/filings/0001628280-26-057358.md) |
| Total assets | $m | [4,545](/filings/0001628280-23-037591.md) | [4,656](/filings/0001628280-24-003796.md) | [4,205](/filings/0001628280-24-020767.md) | [3,932](/filings/0001628280-25-040830.md) | [3,970](/filings/0001628280-24-046443.md) | [3,966](/filings/0001628280-25-004288.md) | [3,975](/filings/0001628280-25-022788.md) | [4,219](/filings/0001628280-26-057358.md) | [4,613](/filings/0001628280-25-049073.md) | [4,805](/filings/0001628280-26-005129.md) | [7,028](/filings/0001628280-26-030777.md) | [7,308](/filings/0001628280-26-057358.md) |
| Current liabilities | $m | [594](/filings/0001628280-23-037591.md) | [658](/filings/0001628280-24-003796.md) | [318](/filings/0001628280-24-020767.md) | [269](/filings/0001628280-25-040830.md) | [305](/filings/0001628280-24-046443.md) | [347](/filings/0001628280-25-004288.md) | [353](/filings/0001628280-25-022788.md) | [393](/filings/0001628280-26-057358.md) | [1,526](/filings/0001628280-25-049073.md) | [3,768](/filings/0001628280-26-005129.md) | [3,865](/filings/0001628280-26-030777.md) | [2,481](/filings/0001628280-26-057358.md) |
| Total liabilities | $m | [3,234](/filings/0001628280-23-037591.md) | [3,378](/filings/0001628280-24-003796.md) | [3,028](/filings/0001628280-24-020767.md) | [2,975](/filings/0001628280-25-040830.md) | [3,074](/filings/0001628280-24-046443.md) | [3,094](/filings/0001628280-25-004288.md) | [3,096](/filings/0001628280-25-022788.md) | [3,084](/filings/0001628280-26-057358.md) | [3,832](/filings/0001628280-25-049073.md) | [3,959](/filings/0001628280-26-005129.md) | [4,055](/filings/0001628280-26-030777.md) | [2,664](/filings/0001628280-26-057358.md) |
| Long-term debt | $m | not reported | not reported | not reported | [2,503](/filings/0001628280-25-040830.md) | [2,569](/filings/0001628280-24-046443.md) | [2,561](/filings/0001628280-25-004288.md) | [2,562](/filings/0001628280-25-022788.md) | [2,563](/filings/0001628280-26-057358.md) | [2,165](/filings/0001628280-25-049073.md) | [47.1](/filings/0001628280-26-005129.md) | [43.2](/filings/0001628280-26-030777.md) | [40.5](/filings/0001628280-26-057358.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [0.0](/filings/0001628280-25-040830.md) | [10.8](/filings/0001628280-24-046443.md) | [9.8](/filings/0001628280-25-004288.md) | [10.3](/filings/0001628280-25-022788.md) | [10.6](/filings/0001628280-26-057358.md) | [1,079](/filings/0001628280-25-049073.md) | [3,240](/filings/0001628280-26-005129.md) | [3,239](/filings/0001628280-26-030777.md) | [1,597](/filings/0001628280-26-057358.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [0.0](/filings/0001628280-25-040830.md) | not reported | not reported | [10.3](/filings/0001628280-25-022788.md) | [10.6](/filings/0001628280-26-057358.md) | [1,079](/filings/0001628280-25-049073.md) | [3,240](/filings/0001628280-26-005129.md) | [3,239](/filings/0001628280-26-030777.md) | [1,597](/filings/0001628280-26-057358.md) |
| Shareholders' equity | $m | [1,311](/filings/0001628280-25-022788.md) | [1,278](/filings/0001628280-25-022788.md) | [1,177](/filings/0001628280-25-022788.md) | [957](/filings/0001628280-26-057358.md) | [896](/filings/0001628280-26-030777.md) | [872](/filings/0001628280-26-030777.md) | [880](/filings/0001628280-26-030777.md) | [1,135](/filings/0001628280-26-057358.md) | [781](/filings/0001628280-26-030777.md) | [847](/filings/0001628280-26-030777.md) | [2,973](/filings/0001628280-26-030777.md) | [4,644](/filings/0001628280-26-057358.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-30) | Q3 FY2024 (2024-03-30) | Q4 FY2024 (2024-06-29) | Q1 FY2025 (2024-09-28) | Q2 FY2025 (2024-12-28) | Q3 FY2025 (2025-03-29) | Q4 FY2025 (2025-06-28) | Q1 FY2026 (2025-09-27) | Q2 FY2026 (2025-12-27) | Q3 FY2026 (2026-03-28) | Q4 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.3)](/filings/0001628280-24-046443.md) | [(1.5) d](/filings/0001628280-25-004288.md) | [(7.0) d](/filings/0001628280-25-022788.md) | [35.5 d](/filings/0001628280-26-057358.md) | [39.6](/filings/0001628280-25-049073.md) | [24.3 d](/filings/0001628280-26-005129.md) | [(1.6) d](/filings/0001628280-26-030777.md) | [64.0 d](/filings/0001628280-26-057358.md) | [57.9](/filings/0001628280-25-049073.md) | [127 d](/filings/0001628280-26-005129.md) | [204 d](/filings/0001628280-26-030777.md) | [363 d](/filings/0001628280-26-057358.md) |
| Capital expenditure | $m | [57.8](/filings/0001628280-24-046443.md) | [31.0 d](/filings/0001628280-25-004288.md) | [19.6 d](/filings/0001628280-25-022788.md) | [24.6 d](/filings/0001628280-26-057358.md) | [74.1](/filings/0001628280-25-049073.md) | [40.2 d](/filings/0001628280-26-005129.md) | [62.8 d](/filings/0001628280-26-030777.md) | [53.9 d](/filings/0001628280-26-057358.md) | [76.2](/filings/0001628280-25-049073.md) | [83.6 d](/filings/0001628280-26-005129.md) | [125 d](/filings/0001628280-26-030777.md) | [167 d](/filings/0001628280-26-057358.md) |
| Share repurchases | $m | [0.0](/filings/0001628280-23-037591.md) | [0.0 d](/filings/0001628280-24-003796.md) | [0.0 d](/filings/0001628280-24-020767.md) | [0.0 d](/filings/0001628280-25-040830.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-01) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-04-01) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-30) | Q3 FY2024 (2024-03-30) | Q1 FY2025 (2024-09-28) | Q2 FY2025 (2024-12-28) | Q3 FY2025 (2025-03-29) | Q1 FY2026 (2025-09-27) | Q2 FY2026 (2025-12-27) | Q3 FY2026 (2026-03-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [68.1](/filings/0001628280-23-037591.md) | [68.3](/filings/0001628280-24-003796.md) | [68.6](/filings/0001628280-24-020767.md) | [66.7](/filings/0001628280-24-046443.md) | [67.2](/filings/0001628280-25-004288.md) | [67.5](/filings/0001628280-25-022788.md) | [68.3](/filings/0001628280-25-049073.md) | [68.9](/filings/0001628280-26-005129.md) | [69.3](/filings/0001628280-26-030777.md) | [78.3](/filings/0001628280-25-049073.md) | [87.8](/filings/0001628280-26-005129.md) | [96.2](/filings/0001628280-26-030777.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 89,700,000 at 2026-08-14, from the cover of the [10-K filed 2026-08-17](/filings/0001628280-26-057358.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.